6% of eligible US individuals were screened for lung cancer in 2022, despite decades-long recommendations.

Lung cancer, the deadliest form of cancer, has low screening rates in the US, despite medical organizations recommending it for high-risk individuals for decades. In 2022, only 6% of eligible people were screened, falling behind screening rates for colon and breast cancers. Numerous complex barriers hinder widespread adoption of lung cancer screening, but early detection significantly improves survival rates.